Feasibility of the inhibitor development for cancer: A systematic approach for drug design

Yu Jiang; Ling Liu; Yichao Geng; Qingsong Li; Daxian Luo; Li Liang; Wei Liu; Weiwei Ouyang; Jianping Hu

doi:10.1371/journal.pone.0306632

Loading metrics

Open Access

Peer-reviewed

Research Article

Feasibility of the inhibitor development for cancer: A systematic approach for drug design

Yu Jiang ,

Contributed equally to this work with: Yu Jiang, Ling Liu

Roles Conceptualization, Methodology, Writing – original draft

Affiliation Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, School of Pharmacy, Chengdu University, Chengdu, China
⨯
Ling Liu ,

Contributed equally to this work with: Yu Jiang, Ling Liu

Roles Resources, Writing – original draft

Affiliations Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, School of Pharmacy, Chengdu University, Chengdu, China, Department of Thoracic Oncology, Affiliated Cancer Hospital, Guizhou Medical University, Guiyang, China
⨯
Yichao Geng,

Roles Conceptualization, Resources

Affiliation Department of Thoracic Oncology, Affiliated Cancer Hospital, Guizhou Medical University, Guiyang, China
⨯
Qingsong Li,

Roles Writing – review & editing

Affiliation Department of Thoracic Oncology, Affiliated Cancer Hospital, Guizhou Medical University, Guiyang, China
⨯
Daxian Luo,

Roles Visualization

Affiliation Department of Thoracic Oncology, Affiliated Cancer Hospital, Guizhou Medical University, Guiyang, China
⨯
Li Liang,

Roles Data curation

Affiliation Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, School of Pharmacy, Chengdu University, Chengdu, China
⨯
Wei Liu,

Roles Project administration, Supervision

Affiliation Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, School of Pharmacy, Chengdu University, Chengdu, China
⨯
Weiwei Ouyang,

Roles Funding acquisition

Affiliation Department of Thoracic Oncology, Affiliated Cancer Hospital, Guizhou Medical University, Guiyang, China

https://orcid.org/0009-0008-1754-3040

⨯
Jianping Hu

Roles Project administration

* E-mail: hjpcdu@163.com.

Affiliation Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, School of Pharmacy, Chengdu University, Chengdu, China

https://orcid.org/0000-0001-7367-3968

⨯

Feasibility of the inhibitor development for cancer: A systematic approach for drug design

Yu Jiang,
Ling Liu,
Yichao Geng,
Qingsong Li,
Daxian Luo,
Li Liang,
Wei Liu,
Weiwei Ouyang,
Jianping Hu

Published: August 22, 2024
https://doi.org/10.1371/journal.pone.0306632

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Free energy
Is the Subject Area "Free energy" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
DNA transcription
Is the Subject Area "DNA transcription" applicable to this article?

Thanks for your feedback.
Small molecules
Is the Subject Area "Small molecules" applicable to this article?

Thanks for your feedback.
Phosphorylation
Is the Subject Area "Phosphorylation" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Dimers
Is the Subject Area "Dimers" applicable to this article?

Thanks for your feedback.
Weak interaction
Is the Subject Area "Weak interaction" applicable to this article?

Thanks for your feedback.